T1	Intervention 10 19	Ezetimibe
T2	Intervention 23 37	LDL-C Lowering
T3	Intervention 42 74	Atherogenic Lipoprotein Profiles
T4	Intervention 78 102	Type 2 Diabetic Patients
T5	Intervention 124 131	Statins
T6	Intervention 160 173	subpopulation
T7	Intervention 177 181	T2DM
T8	Intervention 210 216	statin
T9	Intervention 257 262	LDL-C
T10	Intervention 293 296	CVD
T11	Intervention 302 316	RESEARCH study
T12	Intervention 328 333	LDL-C
T13	Intervention 395 400	lipid
T14	Intervention 445 450	Lipid
T15	Intervention 512 528	open-label study
T16	Intervention 554 560	statin
T17	Intervention 969 974	RLP-C
T18	Intervention 2153 2182	UMIN Clinical Trials Registry
T19	Intervention 2019 2028	ezetimibe
T20	Intervention 2045 2051	statin
T21	Intervention 2081 2128	T2DM patients with insufficient statin response
T22	Intervention 793 798	Lipid
T23	Intervention 847 852	LDL-C
T24	Intervention 1409 1412	EAT
T25	Intervention 1623 1632	Ezetimibe
T26	Intervention 1655 1661	statin
T27	Intervention 1738 1761	intensified-dose statin
T28	Intervention 1911 1936	atherogenic lipid profile
T29	Intervention 1965 1983	sd-LDL-C and RLP-C
